Zonisamide
NDC 68462-130, Zonisamide, capsule, from Glenmark Pharmaceuticals Inc., USA.
- Product NDC
- 68462-130
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077651
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZONISAMIDE100 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; P-Glycoprotein Inhibitors [MoA]; Sulfonamides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-130-01 | 68462013001 | 100 CAPSULE in 1 BOTTLE (68462-130-01) |
| 68462-130-05 | 68462013005 | 500 CAPSULE in 1 BOTTLE (68462-130-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fe15e56e-8b86-4a65-825c-31d37dd81612NADAC price for package 68462013001
GET /v1/drugs/nadac/68462013001NADAC price for package 68462013005
GET /v1/drugs/nadac/68462013005
Use it
Look up 68462-130 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.